Cantitate/Preț
Produs

Comparative Advantage in the Eu: Prior to and After Euro Adoption

Autor Barbara Hillenbrand
en Limba Engleză Paperback – 14 noi 2014
This study examines the impact of the EMU's adoption of the Euro on trade creation, trade diversion and national comparative advantage. It was hypothesized that the Euro adoption would result in 1) trade creation, 2) trade diversion, as well as, 3) an increased focus by individual EMU Nations on the production of goods and services, which exemplify that Nation's areas of greatest strength. The success of the Euro adoption was measured by its impact on trade flows between the EMU and some of its important trading partners (e.g., Canada, China, Iceland, Japan, Mexico, Norway, Switzerland and the USA). The results were mixed--and, both winners and losers emerged. Noteworthy, were the statistically significant increases in average monthly trade for virtually every trade category (e.g., SITC)and type of trade flow (in other words, imports, exports, or total trade). In addition, there was evidence of trade creation within the EMU; and, trade diversion between the EMU and its trading partners (outside the Eurozone). These findings confirm the results obtained by other investigators who have studied the impact on trade for Countries which opt to join a currency union
Citește tot Restrânge

Preț: 64505 lei

Preț vechi: 70114 lei
-8% Nou

Puncte Express: 968

Preț estimativ în valută:
12354 12728$ 10349£

Carte tipărită la comandă

Livrare economică 22 februarie-08 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783639718324
ISBN-10: 3639718321
Pagini: 632
Dimensiuni: 152 x 229 x 36 mm
Greutate: 0.91 kg
Ediția:
Editura: Scholars' Press

Notă biografică

Dr. Barbara Hillenbrand hails from the Midwestern region of the US. She moved to New York City in 1988, where she earned her Doctorate of Professional Studies at Pace University's Lubin School of Business. She has worked as a Consultant in a variety of industries, including, the banking, securities, pharmaceutical and insurance industries.